We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

PHLPP1 Enzyme: A Target for New Sepsis Drugs

News   Aug 14, 2019 | Original story from University of California San Diego

 
PHLPP1 Enzyme: A Target for New Sepsis Drugs

HeLa cells expressing PHLPP (left), the segment with the nuclear localization signal (middle), and that same segment mutated (right). Credit: UC San Diego School of Medicine

 
 
Advertisement
 

RELATED ARTICLES

Advances in Production of Retinal Cells for Treating Blindness

News

Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly.

READ MORE

FDA Approves a Novel Medicine Invented at Scripps Research, For Treatment of Multiple Sclerosis

News

Ozanimod is the latest in a series of novel medicines to originate from the laboratories of Scripps Research.

READ MORE

The National Gene Vector Biorepository

News

Gene therapy investigators can greatly benefit from the resources and services provided by the National Gene Vector Biorepository.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE